Promoting growth in chronic inflammatory disease: lessons from studies of the growth plate

S F Ahmed1, L Sävendahl

  • 1Bone and Endocrine Research Group, Division of Developmental Medicine, University of Glasgow, Royal Hospital for Sick Children, Glasgow, UK.

Hormone Research
|November 27, 2009
PubMed

Insights

Growth disorders in children with chronic inflammation are linked to growth hormone-insulin-like growth factor I (IGF-I) axis disruption. While IGF-I therapy helps, managing inflammation and glucocorticoids remains key for growth.

Area of Science:

  • Pediatric endocrinology
  • Inflammatory diseases
  • Growth disorders

Background:

  • Children with chronic inflammatory diseases often experience growth disorders.
  • Growth is regulated by the growth hormone-insulin-like growth factor I (IGF-I) axis.
  • Glucocorticoids (GCs) and proinflammatory cytokines impact this axis and growth plate function.

Purpose of the Study:

  • To understand how GCs and cytokines affect the growth plate.
  • To explore the rationale for growth-promoting therapies in children with inflammation and growth retardation.

Main Methods:

  • Review of recent advances in understanding GC and cytokine effects on the growth plate.
  • Analysis of the impact on the growth hormone-IGF-I axis.
  • Evaluation of potential therapeutic interventions.

Main Results:

  • Both GCs and proinflammatory cytokines negatively impact growth plate chondrogenesis.
  • Increased local IGF-I exposure can partially ameliorate these adverse effects.
  • IGF-I intervention does not fully normalize growth plate function.

Conclusions:

  • Effective control of the inflammatory disease process is crucial for improving growth.
  • Judicious use of GCs remains a cornerstone of management.
  • While IGF-I shows promise, it does not completely resolve growth plate abnormalities.
Abstract

Related Concept Videos

Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...